ArticleTranslational cancer research2024

ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia.

Chang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.